Serina Therapeutics, Inc. Other Accrued Liabilities, Current
Serina Therapeutics, Inc. (SER) had Other Accrued Liabilities, Current of $266.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Other Accrued Liabilities, Current $266.00K.
- 2026-03-31: Other Accrued Liabilities, Current $350.00K.
- 2025-12-31: Other Accrued Liabilities, Current $164.00K.
- 2025-09-30: Other Accrued Liabilities, Current $153.00K.
| Period end | Other Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $266.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $350.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $164.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $153.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $112.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $364.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $566.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $352.00K 10-Q · filed 2024-11-12 |
| 2023-12-31 | $12.00K 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |